How Is Risk Changing The Relationship Between Sponsors And CROs?
By Ed Miseta, Chief Editor, Clinical Leader

There are many risks faced by companies operating in the clinical trial space. Jamie Macdonald, CEO of global CRO INC Research, has been a keen observer of risk in the industry with deep experience managing through changing approaches in clinical development. He has taken time to speak with customers, colleagues, and competitors in the CRO space about their business relationships. He believes changes currently occurring in risk management are driving many sponsors and CROs to reevaluate the nature of their relationships, and in many cases, changing those relationships for the better.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.